Homepage
Latest Videos
Latest Videos
Brightcove Home Latest Listing
Breast Cancer
Breast Cancer
Brightcove Cards Listing
Prostate Cancer
Brightcove Cards Listing
Multiple Myeloma
Multiple Myeloma
Brightcove Cards Listing
Popular on MedEnrich
Popular in No name
Prostate Cancer11m 38s
Treatment Intensification in Metastatic Castration Sensitive Prostate Cancer
PEACE-1 clinical trial demonstrated that combining ADT and docetaxel with abiraterone acetate plus prednisone (AAP) improves both overall survival (OS) and radiographic progression-free-survival (rPFS) in men with de novo mCSPC.
treatment intensification
mhspc
triplet therapy
peace-1 clinical trial
1

Treatment Intensification in Metastatic Castration...
Prostate Cancer6m 59s
Managing Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC)
3 randomized clinical trials (SPRATAN- Apalutamide), (PROSPER -Enzalutamide) & (ARAMIS -Darolutamide) have shown consistent and almost similar benefit in Metastasis Free Survival in nmCRPC
nmcrpc
metastasis free survival
spartan
prosper & aramis clinical trial
1

Managing Nonmetastatic Castration-Resistant...
Prostate Cancer32m 43s
Treatment Intensification for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): The Time is Now
Treatment intensification for metastatic hormone-sensitive prostate cancer (mHSPC) involves combining multiple therapies to improve patient outcomes.
treatment intensification
androgen deprivation therapy (adt)
androgen receptor signaling inhibitor (arsi)
docetaxel
1

Treatment Intensification for Metastatic...
Critical Care11m 27s
Preventing or reversing vascular calcifications in high risk Chronic kidney disease (CKD) patients
In this video, Dr. Floege talks about the mechanisms of vascular calcifications in patients at high risk of CKD and measures to prevent or reverse the same.
chronic kidney disease
vascular calcification
vitamin k1
magnesium oxide
matrix-gla protein
1

Preventing or reversing vascular calcifications in...
OncoSpecials50m 57s
Understanding Biosimilars -An Expert Perspective
Biosimilars are biologic medicines that are highly similar to an FDA-approved reference product, with no clinically meaningful differences in terms of safety, purity, and potency.
biosimilar
biologics
expert perspective
1

Understanding Biosimilars -An Expert Perspective
Breast Cancer15m 43s
Treatment sequencing - integrating CDK4-6 inhibitors with hormonal therapy in HR+ve ,Her2 Negative Metastatic Breast Cancer
CDK4/6 inhibitors, combined with hormonal therapy, are key in treating HR+/HER2- metastatic breast cancer. Treatment sequencing after progression focuses on personalized strategies, including SERDs, PI3K/mTOR inhibitors, and chemotherapy.
cdk4/6 inhibitors
hormonal therapy
personalized treatment strategies
treatment sequencing
1

Treatment sequencing - integrating CDK4-6...
Breast Cancer11m 28s
ESR1 Mutation in Hormone Receptor Positive Advanced Breast Cancer
ESR1 mutation leads to ligand independent activation of estrogen receptor. ESR1 mutations were first described in 1997 & their role remain underestimated as initial research was focused on primary tumor wherein these mutations were absent.
aromatase inhibitor resistance
hr +ve mbc
esr1 mutation
fulvestrant
1

ESR1 Mutation in Hormone Receptor Positive Advanced...
Myelodysplastic Syndromes7m 3s
Clinical Application of Web Based Tool for Improving MDS Diagnosis
Gradient Based Model based on 10 routinely used parameters (Age, Gender, Hb, WBC, MCV, Platelets, Neutrophils, Monocytes, Glucose, Creatinine) is now available to facilitate non-invasive diagnosis of MDS.
mds
non-invasive diagnosis
1

Clinical Application of Web Based Tool for...
Myelodysplastic Syndromes2m 50s
Maintenance Midostaurin -There Not There
Maintenance therapy with Midostaurin in AML patients with FLT3 mutations has shown potential in improving event-free survival and reducing relapse risk.
maintenance therapy
midostaurin
flt3 mutations
1

Maintenance Midostaurin -There Not There
Multiple Myeloma12m 6s
Double or Triple hit lymphoma : implications for clinicians
Double or triple-hit B-cell lymphomas (DHL and THL) are rare lymphomas associated with poor prognosis.
car-t cell therapy
high risk lymphoma
1

Double or Triple hit lymphoma : implications for...
For Pharmacist
For Pharmacist
Brightcove Cards Listing
Webinars
Webinar Cards Listing
MedBytes
MedBytes
Medbytes Cards Listing
Login
To get access to full MedEnrich experience, please Sign in
Don’t have an account? Register Now